ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Hawaii » Rheumatology

Top Rheumatology Prescribers in Hawaii

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KELLY WACHI M.D.

Rheumatology

381

$19.6K

38
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 32%

$52
Average prescription price

Avg: $158

JAMES MCKOY MD

Rheumatology

469

$121K

95
68 are 65+

25%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 32%

$258
Average prescription price

Avg: $158

DENNIS BOULWARE MD

Rheumatology

715

$327K

158
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 32%

$458
Average prescription price

Avg: $158

DERYLL AMBROCIO MD

Rheumatology

855

$51.6K

142
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 4%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 32%

$60
Average prescription price

Avg: $158

SCOTT KAWAMOTO M.D.

Rheumatology

978

$104K

179
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 32%

$106
Average prescription price

Avg: $158

JANICE ZANE MD

Rheumatology

1,037

$177K

175
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 32%

$170
Average prescription price

Avg: $158

DANIEL BRANDT M.D.

Rheumatology

1,928

$348K

210
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 32%

$180
Average prescription price

Avg: $158

KRISTINE URAMOTO M.D.

Rheumatology

2,473

$370K

189
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 32%

$150
Average prescription price

Avg: $158

ALBERTO SANTOS-OCAMPO M.D.

Rheumatology

3,926

$547K

365
292 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 32%

$139
Average prescription price

Avg: $158

DENNY NAKAYAMA MD

Rheumatology

4,006

$585K

467
401 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 32%

$146
Average prescription price

Avg: $158

MOHAMED ABOYOUSSEF M.D.

Rheumatology

4,008

$716K

462
399 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 32%

$179
Average prescription price

Avg: $158

DAVID JOHN MD

Rheumatology

4,176

$707K

379
322 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 32%

$169
Average prescription price

Avg: $158

PANU LIMPISVASTI MD

Rheumatology

5,112

$665K

281
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 32%

$130
Average prescription price

Avg: $158

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank